SCHEMBL4746466

SCHEMBL4746466

Cc1ccc2c(c1)c(-c1cc3c4ccccc4c(-c4c(C)ccc5c4ccc4c6ccc(C)c7c6c(cc54)-c4ncccc4-7)cc3c3ccccc13)cc1c3ccc(C)c4c3c(cc21)-c1ncccc1-4

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 1/20 0.32
BCHE P06276 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MEN1 O00255 2/20 0.31
MAPT P10636 2/20 0.31
KMT2A Q03164 2/20 0.31
TDP1 Q9NUW8 2/20 0.31
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31
MAPK1 P28482 1/20 0.31
AGTR1 P30556 1/20 0.31
HTT P42858 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CCR1 P32246 1/20 0.31
CCR8 P51685 1/20 0.31
CYP1A2 P05177 1/20 0.30
CYP2C19 P33261 1/20 0.30
GSK3A P49840 1/20 0.30
GSK3B P49841 1/20 0.30
CTSL P07711 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4746461 0.96 TOP2A (0.33) TOP2ABCHEALDH1A1MEN1MAPT
SCHEMBL4746409 0.94 PDK2 (0.33) TOP2ABCHEALDH1A1MEN1MAPT
SCHEMBL4746394 0.93 MEN1 (0.32) TOP2ABCHEALDH1A1MEN1MAPT
SCHEMBL4746272 0.92 MAPT (0.32) TOP2ABCHEMEN1MAPTKMT2A
SCHEMBL4745985 0.92 BCHE (0.33) TOP2ABCHEALDH1A1CTSLPTPRC
SCHEMBL4745945 0.91 HPRT1 (0.37) TOP2ABCHEALDH1A1MAPTMAPK1
SCHEMBL4745849 0.91 CCR1 (0.35) TOP2ABCHEALDH1A1MEN1MAPT
SCHEMBL4745982 0.91 ALDH1A1 (0.34) TOP2ABCHEALDH1A1MEN1MAPT
SCHEMBL4745860 0.90 MAOA (0.35) TOP2ABCHEALDH1A1MAPTKDM4E
SCHEMBL4745880 0.89 MAPT (0.34) TOP2ABCHEALDH1A1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE NR2E3, OR51E2, AZI2 TOP2A 1041/4885BCHE 376/4885ALDH1A1 179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.